NorthCoast Asset Management LLC boosted its position in shares of Express Scripts Holding (NASDAQ:ESRX) by 1.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 398,449 shares of the company’s stock after purchasing an additional 4,788 shares during the quarter. Express Scripts comprises about 2.7% of NorthCoast Asset Management LLC’s holdings, making the stock its 4th biggest holding. NorthCoast Asset Management LLC’s holdings in Express Scripts were worth $29,740,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Ameriprise Financial Inc. lifted its stake in Express Scripts by 23.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock valued at $331,374,000 after acquiring an additional 996,816 shares during the period. Macquarie Group Ltd. lifted its stake in Express Scripts by 8.4% during the 2nd quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock valued at $758,480,000 after acquiring an additional 922,406 shares during the period. Pzena Investment Management LLC lifted its stake in Express Scripts by 23.6% during the 3rd quarter. Pzena Investment Management LLC now owns 3,509,800 shares of the company’s stock valued at $222,241,000 after acquiring an additional 670,922 shares during the period. Schwab Charles Investment Management Inc. lifted its stake in Express Scripts by 21.1% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 3,700,527 shares of the company’s stock valued at $234,318,000 after acquiring an additional 644,208 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its stake in Express Scripts by 40.5% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,879,400 shares of the company’s stock valued at $119,981,000 after acquiring an additional 541,300 shares during the period. 87.86% of the stock is currently owned by institutional investors.

In other Express Scripts news, VP Glen D. Stettin sold 3,448 shares of the firm’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Glen D. Stettin sold 3,449 shares of the firm’s stock in a transaction that occurred on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total transaction of $279,369.00. Following the sale, the vice president now owns 33,715 shares in the company, valued at approximately $2,730,915. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,001 shares of company stock worth $1,249,505. 0.68% of the stock is owned by company insiders.

Several research firms have issued reports on ESRX. Royal Bank of Canada upgraded shares of Express Scripts from a “sector perform” rating to an “outperform” rating and set a $68.00 target price on the stock in a research note on Wednesday, January 31st. BidaskClub cut shares of Express Scripts from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 2nd. Mizuho set a $86.00 price objective on shares of Express Scripts and gave the stock a “hold” rating in a research note on Wednesday, January 24th. Sanford C. Bernstein cut shares of Express Scripts from a “market perform” rating to an “underperform” rating and increased their price objective for the stock from $55.80 to $77.50 in a research note on Tuesday, January 30th. Finally, SunTrust Banks reiterated a “buy” rating and issued a $95.00 price objective on shares of Express Scripts in a research note on Friday, January 12th. Six equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $78.23.

Shares of Express Scripts Holding (NASDAQ ESRX) opened at $75.94 on Wednesday. Express Scripts Holding has a one year low of $55.80 and a one year high of $83.49. The company has a market cap of $42,194.79, a P/E ratio of 10.89, a price-to-earnings-growth ratio of 0.83 and a beta of 0.93. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86.

Express Scripts announced that its board has approved a share repurchase program on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s management believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2018/02/07/northcoast-asset-management-llc-increases-position-in-express-scripts-holding-esrx.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.